Buy Stocks Easy | About Us
August 17, 2022
Buy Stocks Easy | Online Stocks

SLGL


Buy Sol-Gel Technologies Ltd. Stock (symbol: SLGL) Easy Online

Company Name: Sol-Gel Technologies Ltd.

Symbol: SLGL

Sector: Health Care

Industry: Major Pharmaceuticals

IPO: 2018

SLGL Current Share Price

Today's SLGL ( Sol-Gel Technologies Ltd. ) opening price: $9.7234

Yesterday's SLGL ( Sol-Gel Technologies Ltd. ) closing price: $9.8161

Sol-Gel Technologies Ltd. Stock ( symbol: SLGL ) Price Chart since IPO (2018):

12 Months Sol-Gel Technologies Ltd. Stock ( symbol: SLGL ) Price Chart

Popular Questions about Sol-Gel Technologies Ltd. Public Stock ( SLGL )

A: Sol-Gel Technologies Ltd. stock symbol (also called stock or share ticker) is SLGL

A: Sol-Gel Technologies Ltd. IPO (Initial Public Offering) took place on 2018

A: Sol-Gel Technologies Ltd.'s stock (SLGL symbol) price at ther IPO (initial Public Offering) was $9.7234

Q: Is SLGL stock worth buying at the moment?

A: If you were looking for a long-term investment portfolio and had bought the 'Sol-Gel Technologies Ltd. stock (symbol: SLGL) at the beginning of 2019, at the opening share price of $5.9900, with a minimum of $200, by now your shares would be worth $6876 and your profit would be $6676 - SHOW ONLY IF PROFIT.

Buy Sol-Gel Technologies Ltd. Stock Easy Online

Sol-Gel Technologies Ltd. Stock Ticker Price Chart since IPO:





Sol-Gel Technologies Ltd. Stock Price Yesterday



 


Sol-Gel Technologies Ltd. Stock Price – Last Week




 


Sol-Gel Technologies Ltd. Stock Price – Last Month




 


Sol-Gel Technologies Ltd. Stock Value Chart – 12 Months




            

                

                    

                    
                

                
                
Rate this post

                
            

            
            

             

            

        

    



            



    

        

            

                
 Latest Stock News: 

            

        

        



                            

                    


                        
                            http://www.globenewswire.com/news-release/2020/01/02/1965646/0/en/Sol-Gel-Announces-Initiation-of-SGT-210-Phase-1-Proof-of-Concept-Study-in-Palmoplantar-Keratoderma-PPK.html
                            

                                
Sol-Gel Announces Initiation of SGT-210 Phase 1 Proof of Concept Study  in Palmoplantar Keratoderma (PPK)

                                
                                
NESS ZIONA, Israel, Jan.  02, 2020  (GLOBE NEWSWIRE) -- Sol-Gel Tec...


                            

                        
                    

                


                            

                    


                        
                            https://investorplace.com/2019/12/sol-gel-technologies-news-boosts-slgl-stock/
                            

                                
Sol Gel Technologies News: SLGL Stock Skyrockets 80% on Acne Drug Study

                                
                                
Sol Gel Technologies (SLGL) news for Monday concerning an acne drug...


                            

                        
                    

                


                            

                    


                        
                            https://www.benzinga.com/general/biotech/19/12/15051193/why-sol-gel-shares-are-ripping-higher
                            

                                
Why Sol-Gel Shares Are Ripping Higher

                                
                                
Shares of the Israel-based, clinical-stage dermatology company Sol ...


                            

                        
                    

                


                            

                    


                        
                            https://www.marketwatch.com/story/sol-gel-stock-rockets-on-positive-data-from-acne-study-2019-12-30
                            

                                
Sol-Gel stock rockets on positive data from acne study

                                
                                
Shares of Sol-Gel Technologies Ltd. SLGL, -5.82% gained 154% in pre...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/30/1964901/0/en/Sol-Gel-Announces-Positive-Top-Line-Phase-3-Trial-Results-of-Twyneo-for-the-Treatment-of-Acne-Vulgaris.html
                            

                                
Sol-Gel Announces Positive Top-Line Phase 3 Trial Results of Twyneo® for the Treatment of Acne Vulgaris

                                
                                
NESS ZIONA, Israel, Dec.  30, 2019  (GLOBE NEWSWIRE) --  Sol-Gel Te...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/16/1930396/0/en/Sol-Gel-to-Present-on-Potential-of-Sol-Gel-Microencapsulation-Technology-in-Rosacea-at-39th-Annual-Fall-Clinical-Dermatology-Conference.html
                            

                                
Sol-Gel to Present on Potential of Sol-Gel Microencapsulation Technology in Rosacea at 39th Annual Fall Clinical Dermatology Conference

                                
                                
NESS ZIONA, Israel, Oct.  16, 2019  (GLOBE NEWSWIRE) -- Sol-Gel Tec...


                            

                        
                    

                


                            

                    


                        
                            https://www.marketwatch.com/story/sol-gel-technologies-reports-positive-results-in-trials-of-treatment-for-papulopustular-rosacea-2019-07-08-7912256
                            

                                
Sol-Gel Technologies reports positive results in trials of treatment for papulopustular rosacea

                                
                                
Sol-Gel Technologies Ltd.  said Monday that two late-stage trials o...


                            

                        
                    

                


                            

                    


                        
                            https://seekingalpha.com/article/4315670-sol-gel-shines-in-treating-2-skin-disorders-ndas-expected-for-indications-in-2020
                            

                                
Sol-Gel Shines In Treating 2 Skin Disorders, NDAs Expected For Both Indications In 2020

                                
                                
Sol-Gel Shines In Treating 2 Skin Disorders, NDAs Expected For Both...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2020/01/02/1965646/0/en/Sol-Gel-Announces-Initiation-of-SGT-210-Phase-1-Proof-of-Concept-Study-in-Palmoplantar-Keratoderma-PPK.html
                            

                                
Sol-Gel Announces Initiation of SGT-210 Phase 1 Proof of Concept Study  in Palmoplantar Keratoderma (PPK)

                                
                                
NESS ZIONA, Israel, Jan.  02, 2020  (GLOBE NEWSWIRE) -- Sol-Gel Tec...


                            

                        
                    

                


                            

                    


                        
                            https://investorplace.com/2019/12/sol-gel-technologies-news-boosts-slgl-stock/
                            

                                
Sol Gel Technologies News: SLGL Stock Skyrockets 80% on Acne Drug Study

                                
                                
Sol Gel Technologies (SLGL) news for Monday concerning an acne drug...


                            

                        
                    

                


                            

                    


                        
                            https://www.benzinga.com/general/biotech/19/12/15051193/why-sol-gel-shares-are-ripping-higher
                            

                                
Why Sol-Gel Shares Are Ripping Higher

                                
                                
Shares of the Israel-based, clinical-stage dermatology company Sol ...


                            

                        
                    

                


                            

                    


                        
                            https://www.marketwatch.com/story/sol-gel-stock-rockets-on-positive-data-from-acne-study-2019-12-30
                            

                                
Sol-Gel stock rockets on positive data from acne study

                                
                                
Shares of Sol-Gel Technologies Ltd. SLGL, -5.82% gained 154% in pre...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/12/30/1964901/0/en/Sol-Gel-Announces-Positive-Top-Line-Phase-3-Trial-Results-of-Twyneo-for-the-Treatment-of-Acne-Vulgaris.html
                            

                                
Sol-Gel Announces Positive Top-Line Phase 3 Trial Results of Twyneo® for the Treatment of Acne Vulgaris

                                
                                
NESS ZIONA, Israel, Dec.  30, 2019  (GLOBE NEWSWIRE) --  Sol-Gel Te...


                            

                        
                    

                


                            

                    


                        
                            http://www.globenewswire.com/news-release/2019/10/16/1930396/0/en/Sol-Gel-to-Present-on-Potential-of-Sol-Gel-Microencapsulation-Technology-in-Rosacea-at-39th-Annual-Fall-Clinical-Dermatology-Conference.html
                            

                                
Sol-Gel to Present on Potential of Sol-Gel Microencapsulation Technology in Rosacea at 39th Annual Fall Clinical Dermatology Conference

                                
                                
NESS ZIONA, Israel, Oct.  16, 2019  (GLOBE NEWSWIRE) -- Sol-Gel Tec...


                            

                        
                    

                


                            

                    


                        
                            https://www.marketwatch.com/story/sol-gel-technologies-reports-positive-results-in-trials-of-treatment-for-papulopustular-rosacea-2019-07-08-7912256
                            

                                
Sol-Gel Technologies reports positive results in trials of treatment for papulopustular rosacea

                                
                                
Sol-Gel Technologies Ltd.  said Monday that two late-stage trials o...


                            

                        
                    

                


            
        

    




    
    





	
	  

	  All right reserved Buy Stocks Easy , 2019.